Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-013364

Chief Development Officer sold 239 shares at $8.76 ($2,094)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-05-18 Sale −239 $8.76 $2,094 90,447 D
Open-market sales · 239 sh · avg $8.76 · $2,094
Loading xslF345X04/doc4.xml…